Summary of findings: tobramycin for inhalation powder vs tobramycin
Survival: number of deaths · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
1 finding from 1 review
- Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis 2022 · Cochrane Headline outcomes only4.76 [0.25, 91.62]1 study · 517 participantsLow